Catch up on news from Murrieta Genomics by checking out our April 2020 newsletter here.
Catch up on news from Murrieta Genomics by checking out our April 2020 newsletter here.
Like everyone, we are doing what we can to keep ourselves and those we love safe during this trying time.
Today we launched our newsletter, a monthly update to keep everyone in the loop. You can view it here.
John Powers, President of Murrieta Genomics and CEO of SimplSeq, our wholly owned subsidiary, was interviewed recently on Beyone with
Tx Genetic Research was founded on the goal of helping people treat their “inside skin” well for life.
Company to Utilize Microsoft Azure for Data Management and Analytics
Overview of company’s business and revenue model will be presented at special dinner meeting at Bear Creek Golf Club.
Goal is to provide a greater amount of personalized patient data to assist with pharmacogenomic and personalized medicine research
Catch up on news from Murrieta Genomics by checking out our April 2020 newsletter here.
Like everyone, we are doing what we can to keep ourselves and those we love safe during this trying time.
Today we launched our newsletter, a monthly update to keep everyone in the loop. You can view it here.
John Powers, President of Murrieta Genomics and CEO of SimplSeq, our wholly owned subsidiary, was interviewed recently on Beyone with
Tx Genetic Research was founded on the goal of helping people treat their “inside skin” well for life.
Company to Utilize Microsoft Azure for Data Management and Analytics
Overview of company’s business and revenue model will be presented at special dinner meeting at Bear Creek Golf Club.
Goal is to provide a greater amount of personalized patient data to assist with pharmacogenomic and personalized medicine research
Like everyone, we are doing what we can to keep ourselves and those we love safe during this trying time.
Today we launched our newsletter, a monthly update to keep everyone in the loop. You can view it here.
John Powers, President of Murrieta Genomics and CEO of SimplSeq, our wholly owned subsidiary, was interviewed recently on Beyone with
Several biotech companies have been thriving in Murrieta due to a city council decision that started with an idea to